Receptors, Estrogen

"Receptors, Estrogen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important.

Descriptor ID	D011960
MeSH Number(s)	D12.776.826.750.350 D12.776.930.778.350
Concept/Terms	Receptors, Estrogen Receptors, Estrogen Estrogen Receptors Receptors, Estrogen, Type II Receptors, Estrogen, Type II Estrogen Receptor Type II Estrogen Receptors Type II Estrogen Nuclear Receptor Estrogen Nuclear Receptor Nuclear Receptor, Estrogen Receptor, Estrogen Nuclear Receptors, Estrogen, Type I Receptors, Estrogen, Type I Estrogen Receptor Type I Estrogen Receptors Type I

Below are MeSH descriptors whose meaning is more general than "Receptors, Estrogen".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Receptors, Cytoplasmic and Nuclear [D12.776.826]
Receptors, Steroid [D12.776.826.750]
Receptors, Estrogen [D12.776.826.750.350]
Transcription Factors [D12.776.930]
Receptors, Steroid [D12.776.930.778]
Receptors, Estrogen [D12.776.930.778.350]

Below are MeSH descriptors whose meaning is related to "Receptors, Estrogen".

Below are MeSH descriptors whose meaning is more specific than "Receptors, Estrogen".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Receptors, Estrogen" by people in this website by year, and whether "Receptors, Estrogen" was a major or minor topic of these publications.

Bar chart showing 126 publications over 27 distinct years, with a maximum of 16 publications in 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1996	1	0	1
1997	0	1	1
2000	1	0	1
2001	1	0	1
2002	1	3	4
2003	2	4	6
2004	2	3	5
2005	3	5	8
2006	4	2	6
2007	3	4	7
2008	3	2	5
2009	0	3	3
2010	3	3	6
2011	3	3	6
2012	1	4	5
2013	8	8	16
2014	3	3	6
2015	2	5	7
2016	2	2	4
2017	1	2	3
2018	4	3	7
2019	2	2	4
2020	0	2	2
2021	1	3	4
2022	1	2	3
2024	1	3	4

Below are the most recent publications written about "Receptors, Estrogen" by people in Profiles.

Wang Q, Huang N, Psaltis JB, Gahtani RM, Yan G, Lu D, Cahalan SR, Shi X, Copeland RL, Haddad BR, Martin MB. Activation of estrogen-related receptor ? by calcium and cadmium. Front Endocrinol (Lausanne). 2024; 15:1400022.

View in: PubMed
Hanafi D, Onyenwoke RU, Kimbro KS. The G-Protein-Coupled Estrogen Receptor Selective Agonist G-1 Attenuates Cell Viability and Migration in High-Grade Serous Ovarian Cancer Cell Lines. Int J Mol Sci. 2024 Jun 13; 25(12).

View in: PubMed
Hixon JC, Rivas Zarete JI, White J, Hilaire M, Muhammad A, Yusuf AP, Adu-Addai B, Yates CC, Mahavadi S. Epigenetic Modulation of GPER Expression in Gastric and Colonic Smooth Muscle of Male and Female Non-Obese Diabetic (NOD) Mice: Insights into H3K4me3 and H3K27ac Modifications. Int J Mol Sci. 2024 May 11; 25(10).

View in: PubMed
Ping J, Jia G, Cai Q, Guo X, Tao R, Ambrosone C, Huo D, Ambs S, Barnard ME, Chen Y, Garcia-Closas M, Gu J, Hu JJ, John EM, Li CI, Nathanson K, Nemesure B, Olopade OI, Pal T, Press MF, Sanderson M, Sandler DP, Yoshimatsu T, Adejumo PO, Ahearn T, Brewster AM, Hennis AJM, Makumbi T, Ndom P, O'Brien KM, Olshan AF, Oluwasanu MM, Reid S, Yao S, Butler EN, Huang M, Ntekim A, Li B, Troester MA, Palmer JR, Haiman CA, Long J, Zheng W. Using genome and transcriptome data from African-ancestry female participants to identify putative breast cancer susceptibility genes. Nat Commun. 2024 May 02; 15(1):3718.

View in: PubMed
Muhammad A, Hixon JC, Pharmacy Yusuf A, Rivas Zarete JI, Johnson I, Miller J, Adu-Addai B, Yates C, Mahavadi S. Sex-specific epigenetics drive low GPER expression in gastrointestinal smooth muscles in type 2 diabetic mice. Sci Rep. 2024 03 07; 14(1):5633.

View in: PubMed
Zavala VA, Casavilca-Zambrano S, Navarro-V?squez J, Casta?eda CA, Valencia G, Morante Z, Calder?n M, Abugattas JE, G?mez H, Fuentes HA, Liendo-Picoaga R, Cotrina JM, Monge C, Neciosup SP, Huntsman S, Hu D, S?nchez SE, Williams MA, N??ez-Marrero A, Godoy L, Hechmer A, Olshen AB, Dutil J, Ziv E, Zabaleta J, Gelaye B, V?squez J, G?lvez-Nino M, Enriquez-Vera D, Vidaurre T, Fejerman L. Association between Ancestry-Specific 6q25 Variants and Breast Cancer Subtypes in Peruvian Women. Cancer Epidemiol Biomarkers Prev. 2022 08 02; 31(8):1602-1609.

View in: PubMed
Liu D, Hao Q, Li J, Li Q, Wang K, Geng Q, Wu Y, Vadgama JV, Wu Y. ZBED2 expression enhances interferon signaling and predicts better survival of estrogen receptor-negative breast cancer patients. Cancer Commun (Lond). 2022 07; 42(7):663-667.

View in: PubMed
Sinyani A, Idowu K, Shunmugam L, Kumalo HM, Khan R. A molecular dynamics perspective into estrogen receptor inhibition by selective flavonoids as alternative therapeutic options. J Biomol Struct Dyn. 2023 06; 41(9):4093-4105.

View in: PubMed
Sarink D, White KK, Loo LWM, Wu AH, Wilkens LR, Le Marchand L, Park SY, Setiawan VW, Merritt MA. Racial/ethnic differences in postmenopausal breast cancer risk by hormone receptor status: The multiethnic cohort study. Int J Cancer. 2022 01 15; 150(2):221-231.

View in: PubMed
Fujii T, Masuda H, Cheng YC, Yang F, Sahin AA, Naoi Y, Matsunaga Y, Raghavendra A, Sinha AK, Fernandez JRE, James A, Yamagishi K, Matsushima T, Schuetz R, Tripathy D, Tada S, Jackson RS, Noguchi S, Nakamura S, Acoba JD, Ueno NT. A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores. Breast Cancer Res Treat. 2021 Sep; 189(2):455-461.

View in: PubMed

People

Explore

Similar Concepts

Top Journals